Applied Therapeutics shares are trading lower after the company reported a year-over-year decrease in Q3 EPS results.
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics reported a year-over-year decrease in Q3 earnings per share (EPS), causing its shares to trade lower.
November 09, 2023 | 7:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics' stock is trading lower due to a decrease in Q3 EPS compared to the previous year.
Earnings per share (EPS) is a key indicator of a company's profitability. A decrease in EPS often leads to a decrease in share price as it indicates lower profitability. Therefore, the decrease in Applied Therapeutics' Q3 EPS is likely causing its shares to trade lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100